BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 21629301)

  • 1. Phenotypic heterogeneity in British patients with a founder mutation in the FHL1 gene.
    Sarkozy A; Windpassinger C; Hudson J; Dougan CF; Lecky B; Hilton-Jones D; Eagle M; Charlton R; Barresi R; Lochmüller H; Bushby K; Straub V
    Eur J Hum Genet; 2011 Oct; 19(10):1038-44. PubMed ID: 21629301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reducing body myopathy and other FHL1-related muscular disorders.
    Schessl J; Feldkirchner S; Kubny C; Schoser B
    Semin Pediatr Neurol; 2011 Dec; 18(4):257-63. PubMed ID: 22172421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel mutation in FHL1 in a family with X-linked scapuloperoneal myopathy: phenotypic spectrum and structural study of FHL1 mutations.
    Chen DH; Raskind WH; Parson WW; Sonnen JA; Vu T; Zheng Y; Matsushita M; Wolff J; Lipe H; Bird TD
    J Neurol Sci; 2010 Sep; 296(1-2):22-9. PubMed ID: 20633900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel FHL1 mutation in a family with reducing body myopathy.
    Schreckenbach T; Henn W; Kress W; Roos A; Maschke M; Feiden W; Dillmann U; Schulz JB; Weis J; Claeys KG
    Muscle Nerve; 2013 Jan; 47(1):127-34. PubMed ID: 23169582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An X-linked myopathy with postural muscle atrophy and generalized hypertrophy, termed XMPMA, is caused by mutations in FHL1.
    Windpassinger C; Schoser B; Straub V; Hochmeister S; Noor A; Lohberger B; Farra N; Petek E; Schwarzbraun T; Ofner L; Löscher WN; Wagner K; Lochmüller H; Vincent JB; Quasthoff S
    Am J Hum Genet; 2008 Jan; 82(1):88-99. PubMed ID: 18179888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skeletal muscle biopsy analysis in reducing body myopathy and other FHL1-related disorders.
    Malfatti E; Olivé M; Taratuto AL; Richard P; Brochier G; Bitoun M; Gueneau L; Laforêt P; Stojkovic T; Maisonobe T; Monges S; Lubieniecki F; Vasquez G; Streichenberger N; Lacène E; Saccoliti M; Prudhon B; Alexianu M; Figarella-Branger D; Schessl J; Bonnemann C; Eymard B; Fardeau M; Bonne G; Romero NB
    J Neuropathol Exp Neurol; 2013 Sep; 72(9):833-45. PubMed ID: 23965743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical, histological and genetic characterization of reducing body myopathy caused by mutations in FHL1.
    Schessl J; Taratuto AL; Sewry C; Battini R; Chin SS; Maiti B; Dubrovsky AL; Erro MG; Espada G; Robertella M; Saccoliti M; Olmos P; Bridges LR; Standring P; Hu Y; Zou Y; Swoboda KJ; Scavina M; Goebel HH; Mitchell CA; Flanigan KM; Muntoni F; Bönnemann CG
    Brain; 2009 Feb; 132(Pt 2):452-64. PubMed ID: 19181672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consequences of mutations within the C terminus of the FHL1 gene.
    Schoser B; Goebel HH; Janisch I; Quasthoff S; Rother J; Bergmann M; Müller-Felber W; Windpassinger C
    Neurology; 2009 Aug; 73(7):543-51. PubMed ID: 19687455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exome Sequencing Identified a Splice Site Mutation in FHL1 that Causes Uruguay Syndrome, an X-Linked Disorder With Skeletal Muscle Hypertrophy and Premature Cardiac Death.
    Xue Y; Schoser B; Rao AR; Quadrelli R; Vaglio A; Rupp V; Beichler C; Nelson SF; Schapacher-Tilp G; Windpassinger C; Wilcox WR
    Circ Cardiovasc Genet; 2016 Apr; 9(2):130-5. PubMed ID: 26933038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FHL1-related myopathy may not be classified by reducing bodies in muscle biopsy.
    Chen T; Lu X; Shi Q; Guo J; Wang H; Wang Q; Yin X; Zhang Y; Pu C; Zhou D
    Neuromuscul Disord; 2020 Feb; 30(2):165-172. PubMed ID: 32001145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Dominant C150Y Mutation in FHL1 Induces Structural Alterations in LIM2 Domain Causing Protein Aggregation In Human and Drosophila Indirect Flight Muscles.
    Santhoshkumar R; Preethish-Kumar V; Mangalaparthi KK; Unni S; Padmanabhan B; T S KP; Nongthomba U; Atchayaram N; Narayanappa G
    J Mol Neurosci; 2021 Nov; 71(11):2324-2335. PubMed ID: 33515430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fhl1 W122S causes loss of protein function and late-onset mild myopathy.
    Emmanuele V; Kubota A; Garcia-Diaz B; Garone C; Akman HO; Sánchez-Gutiérrez D; Escudero LM; Kariya S; Homma S; Tanji K; Quinzii CM; Hirano M
    Hum Mol Genet; 2015 Feb; 24(3):714-26. PubMed ID: 25274776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Childhood reducing body myopathy caused by FHL1 gene variation in a child].
    Wei CJ; Wang ZX; Chang XZ; Lyu JL; Ge L; Fan YB; Zhang YH; Xiong H
    Zhonghua Er Ke Za Zhi; 2020 Feb; 58(2):147-149. PubMed ID: 32102154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel FHL1 mutation variant identified in a patient with nonobstructive hypertrophic cardiomyopathy and myopathy - a case report.
    Giucă A; Mitu C; Popescu BO; Bastian AE; Capşa R; Mursă A; Rădoi V; Popescu BA; Jurcuţ R
    BMC Med Genet; 2020 Sep; 21(1):188. PubMed ID: 32993534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial reducing body myopathy with cytoplasmic bodies and rigid spine revisited: identification of a second LIM domain mutation in FHL1.
    Schessl J; Columbus A; Hu Y; Zou Y; Voit T; Goebel HH; Bönnemann CG
    Neuropediatrics; 2010 Feb; 41(1):43-6. PubMed ID: 20571991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. X-linked Recessive Distal Myopathy With Hypertrophic Cardiomyopathy Caused by a Novel Mutation in the FHL1 Gene.
    D'Arcy C; Kanellakis V; Forbes R; Wilding B; McGrath M; Howell K; Ryan M; McLean C
    J Child Neurol; 2015 Aug; 30(9):1211-7. PubMed ID: 25246303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Four and a half LIM protein 1 gene mutations cause four distinct human myopathies: a comprehensive review of the clinical, histological and pathological features.
    Cowling BS; Cottle DL; Wilding BR; D'Arcy CE; Mitchell CA; McGrath MJ
    Neuromuscul Disord; 2011 Apr; 21(4):237-51. PubMed ID: 21310615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations of the FHL1 gene cause Emery-Dreifuss muscular dystrophy.
    Gueneau L; Bertrand AT; Jais JP; Salih MA; Stojkovic T; Wehnert M; Hoeltzenbein M; Spuler S; Saitoh S; Verschueren A; Tranchant C; Beuvin M; Lacene E; Romero NB; Heath S; Zelenika D; Voit T; Eymard B; Ben Yaou R; Bonne G
    Am J Hum Genet; 2009 Sep; 85(3):338-53. PubMed ID: 19716112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscle hypertrophy as the presenting sign in a patient with a complete FHL1 deletion.
    Willis TA; Wood CL; Hudson J; Polvikoski T; Barresi R; Lochmüller H; Bushby K; Straub V
    Clin Genet; 2016 Aug; 90(2):166-70. PubMed ID: 27409453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FHL1 mutants that cause clinically distinct human myopathies form protein aggregates and impair myoblast differentiation.
    Wilding BR; McGrath MJ; Bonne G; Mitchell CA
    J Cell Sci; 2014 May; 127(Pt 10):2269-81. PubMed ID: 24634512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.